{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:40:41Z","timestamp":1790894441215,"version":"4.1.0"},"reference-count":63,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T00:00:00Z","timestamp":1709424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T00:00:00Z","timestamp":1709424000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dermatomyositis (DM) is a systemic autoimmune disease with variable clinical presentations, including inflammation in the skin, muscle, lungs, and\/or joints. Current therapeutic strategies in DM typically include broad immunosuppression; however, the currently used modalities are not universally effective and are associated with various side effects, including risk of infection. There is currently a highly unmet need for more effective and well\u2010tolerated therapies. Recent years have witnessed increased interest in pharmaceutical development of new therapeutic strategies for DM. This review aims to summarize the landscape of therapies that are currently being tested or planned in patients with DM. These therapies have a wide variety of immunological targets, including T cells, B cells, inflammatory signaling pathways, type I interferons, autoantibodies, and other targets.<\/jats:p>","DOI":"10.1111\/1346-8138.17170","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:28:18Z","timestamp":1709512098000},"page":"920-926","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Novel therapeutic targets in dermatomyositis"],"prefix":"10.1111","volume":"51","author":[{"given":"Christina","family":"Bax","sequence":"first","affiliation":[{"name":"Department of Dermatology Stanford University School of Medicine  Redwood City California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel","family":"Aghdasi","sequence":"additional","affiliation":[{"name":"Department of Dermatology Stanford University School of Medicine  Redwood City California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fiorentino","sequence":"additional","affiliation":[{"name":"Department of Dermatology Stanford University School of Medicine  Redwood City California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,3,3]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06144.x"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.854848"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.02.748"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2006.02150.x"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.suppl_1.i21"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.11.4212"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24936"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2011.02.003"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002960050070"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202470"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60454-7"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27221"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11493"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1006\/clim.1999.4743"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211751"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42450"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-200311000-00006"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2011.01501.x"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15117"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.101321"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20849"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker088"},{"key":"e_1_2_8_24_1","first-page":"1009","article-title":"Rituximab in the treatment of dermatomyositis and other inflammatory myopathies. a report of 4 cases and review of the literature","volume":"27","author":"Rios Fern\u00e1ndez R","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20219"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37754"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew396"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00359-9"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.080960"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12220"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2107725"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02017-5"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00023-5"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.8753"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead330"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20464"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.8.4154"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029161"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.2119\/2006-00085.Baechler"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22928"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15006"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.139949"},{"key":"e_1_2_8_43_1","volume-title":"A Study In Adults With Moderate To Severe Dermatomyositis","author":"ClinicalTrials.gov [Internet]"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18223"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13915"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1412997"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41602"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-023-06567-y"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.08.025"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.962585"},{"key":"e_1_2_8_51_1","volume-title":"A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis","author":"ClinicalTrials.gov [Internet]"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.07.122"},{"key":"e_1_2_8_53_1","volume-title":"A Study to Assess the Long\u2010term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy (ALKIVIA+)","author":"ClinicalTrials.gov [Internet]"},{"key":"e_1_2_8_54_1","volume-title":"Study of M5049 in DM and PM Participants (NEPTUNIA)","author":"ClinicalTrials.gov [Internet]"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2117912"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M116.064675"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00159-9"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww122"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-200406000-00018"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270402"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180060"},{"key":"e_1_2_8_62_1","first-page":"S489","article-title":"A pilot study of eculizumab in patients with dermatomyositis","volume":"46","author":"Takada K","year":"2002","journal-title":"Arthritis Rheum"},{"key":"e_1_2_8_63_1","volume-title":"Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis","author":"ClinicalTrials.gov [Internet]"},{"key":"e_1_2_8_64_1","volume-title":"A Phase 2 Study of KZR\u2010616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis (PRESIDIO)","author":"ClinicalTrials.gov [Internet]"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1346-8138.17170","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1346-8138.17170","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1346-8138.17170","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T07:56:04Z","timestamp":1770537364000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1346-8138.17170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,3]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1111\/1346-8138.17170"],"URL":"https:\/\/doi.org\/10.1111\/1346-8138.17170","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,3]]},"assertion":[{"value":"2024-02-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}